BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...
A wrist-worn, AI-driven transcutaneous peripheral nerve stimulator is linked to greater improvement in patients with ...
Please provide your email address to receive an email when new articles are posted on . A Bay Area bioelectronic medicine company announced the commercial launch of its next-generation Cala kIQ System ...
SAN MATEO, Calif.--(BUSINESS WIRE)--Cala, the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced meeting the primary endpoint on an interim analysis of a ...
More than 7 million Americans struggle with essential tremor (ET), but only one in 10 ET patients is satisfied with their current treatment. Cala Health — a San Mateo, California-based bioelectronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results